stock · yahoo

Danaher Corporation

DHR

$229.04
▼ 2.46 (-1.06%)
polled · warming up

Below: live stock price for Danaher Corporation (DHR), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.

Danaher Corporation (DHR) is a Healthcare company based in United States. Operating in Diagnostics & Research, it employs about 58,000 people. Over the past year DHR traded between 160.93 and 242.8 USD. Trailing P/E sits near 40.83 on a market cap of about 161.01B USD. It currently yields 0.70% in dividends.

Day
-1.06%
-2.46
Week
+4.20%
+9.23
Month
+8.13%
+17.23
Year
—
Prev close
$231.50
Volume (24h)
$805.38M
Market cap
$161.01B
Currency
USD

Score

55/ 100 · Mixed

Coverage: 7/7
  • Value44
  • Quality59
  • Momentum40
  • Growth63
  • Risk85
  • Dividend52
  • Liquidity41

Composite of public market data. Informational only — not investment advice.

Trend projection

Where the recent trend points if it continues.

UptrendFit 66%Pace +0.22% per bar
+5 bars+20 bars+60 bars+120 bars
+5 bars
231.0185
+0.86%
Bull261.3331
Bear204.2205
+20 bars
233.7766
+2.07%
Bull299.1548
Bear182.6863
+60 bars
234.8523
+2.54%
Bull359.9887
Bear153.2148
+120 bars
234.8919
+2.55%
Bull429.7305
Bear128.3926

Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0276 USD.

Interpretation

Composite signals look mixed. Strength: risk profile with weakness: momentum. Price sits near the upper third of the recent range, trend is sloping upward.

Descriptive observation — not investment advice.

Score breakdown

Raw values behind each pillar so you can see what the composite is reading.

  • Value
    44/100

    Value looks weak — driven by P/E (40.83).

    P/E:40.83P/B:3.06PEG:1.37
  • Quality
    59/100

    Quality looks mixed — driven by Gross margin (58.75%).

    ROE:7.61%ROA:3.95%Profit margin:15.95%Gross margin:58.75%
  • Momentum
    40/100

    Momentum looks weak — driven by 52w change (9.91%).

    52w change:9.91%
  • Growth
    63/100

    Growth looks solid — driven by Earnings growth (59.70%).

    Revenue growth:5.50%Earnings growth:59.70%
  • Risk
    85/100

    Risk looks strong — driven by Debt / equity (52.97).

    Beta:0.8Debt / equity:52.97Short interest:1.43%
  • Dividend
    52/100

    Dividend looks mixed — driven by Payout ratio (25.67%).

    Dividend yield:0.70%Payout ratio:25.67%
  • Liquidity
    41/100

    Liquidity looks weak — driven by Current ratio (1.65).

    Current ratio:1.65Quick ratio:1.15

Derived from public market data — informational, not investment advice.

Price report

How this asset has actually moved over the last 250 days.

Position in range83%
160.93 low242.8 high

Where the price sits between the window low and high.

Volatility (annualised)
30.7%

Spread of returns. Higher means larger swings in both directions.

Max drawdown
-33.1%

Worst peak-to-trough fall inside the window.

Below period high
-5.7%

Current price against the highest point in the window.

Best day
+7.46%
Worst day
-10.99%
Up days
52%

Share of days that closed above the one before.

Current streak
1 down
Typical day swing
2.6%

Average high-to-low spread within a single day.

Volume vs average
+5%

Last 10 days against the whole window.

Descriptive statistics over past prices — not a forecast and not investment advice.

Reference levels

Fibonacci retracements and extensions across the recent range.

60 bars

Reference only — not investment advice.

These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.

Next level above
244.7622 USD+6.86%
Fib +27.2% extension
Next level below
222.8319 USD-2.71%
Fib 23.6% retracement

Levels derived from: 233.02 high → 189.85 low · 60 bars

  • Resistance
    Fib +161.8% extension
    not reached
    302.8691 USD
    +32.23% from current
  • Resistance
    Fib +100% extension
    not reached
    276.19 USD
    +20.59% from current
  • Resistance
    Fib +61.8% extension
    not reached
    259.6991 USD
    +13.39% from current
  • Resistance
    Fib +27.2% extension
    not reached
    244.7622 USD
    +6.86% from current
  • Current
    229.04 USD
  • Support
    Fib 23.6% retracementNearest
    tested 8×
    222.8319 USD
    -2.71% from current
  • Support
    Fib 38.2% retracement
    tested 14×
    216.5291 USD
    -5.46% from current
  • Support
    Fib 50% midpoint
    tested 10×
    211.435 USD
    -7.69% from current
  • Support
    Fib 61.8% retracement
    tested 11×
    206.3409 USD
    -9.91% from current
  • Support
    Fib 78.6% retracement
    tested 7×
    199.0884 USD
    -13.08% from current
  • Support
    Fib −27.2% extension
    not reached
    178.1078 USD
    -22.24% from current
  • Support
    Fib −61.8% extension
    not reached
    163.1709 USD
    -28.76% from current
  • Support
    Fib −100% extension
    not reached
    146.68 USD
    -35.96% from current
How to read this

We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.

“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.

This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.

Financials

52w high
$242.80
52w low
$160.93
52w change
9.91%
Day high
$231.92
Day low
$228.37
P/E (TTM)
40.83
Forward P/E
24.64
PEG
1.37
Price / Book
3.06
Beta (5Y)
0.8
Enterprise value
184.53B
EV / Revenue
7.35
EV / EBITDA
22.99
EPS (TTM)
$5.61
Forward EPS
$9.30
Dividend yield
0.70%
Dividend rate
$1.60
Payout ratio
25.67%
Revenue (TTM)
25.11B
EBITDA
8.03B
Free cash flow
4.33B
Total cash
4.35B
Total debt
27.86B
Debt / Equity
52.97
Current ratio
1.65
Quick ratio
1.15
Profit margin
15.95%
Gross margin
58.75%
Return on assets
3.95%
Return on equity
7.61%
Shares outstanding
702.99M
Float
625.78M
Sector: HealthcareIndustry: Diagnostics & ResearchHQ: United StatesEmployees: 58Kwww.danaher.com

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Analyst & Risk

Consensus
Strong Buy
Mean rating1.48 / 5
Analysts22
Next earnings2026-10-21
Strong buy 4Buy 17Hold 4
Analyst price target
$244.14
Mean target · 22 analysts
+6.6%
upside
Low $200.00Now $229.04High $310.00
Beta (vs S&P 500)
0.8
less volatile
52-week change
9.91%
Short % of float
1.43%
Short ratio (days)
2.17
Debt / Equity
52.97
very high leverage
Current ratio
1.65
Quick ratio
1.15
ROE
7.61%
ROA
3.95%
PEG ratio
1.37
fair
EV / Revenue
7.35
EV / EBITDA
22.99
Revenue growth
5.50%
Earnings growth
59.70%
EBITDA
8.03B
Free cash flow
4.33B
Total cash
4.35B
Total debt
27.86B
Insider holdings
10.82%
Institutional
84.25%

Recent rating changes

  • 2026-10-13Morgan StanleyOverweight → Overweightmain
  • 2026-10-13TD CowenBuy → Buymain
  • 2026-10-07BarclaysOverweight → Overweightmain
  • 2026-10-05RBC CapitalOutperform → Outperformmain
  • 2026-10-01GuggenheimBuy → Buymain
  • 2026-07-22Wells FargoEqual-Weight → Equal-Weightmain
  • 2026-07-22TD CowenBuy → Buymain
  • 2026-07-22StifelBuy → Buymain

Recent news

Related

Other assets in this category.

Learn the terms

Live discussion

Sign in to join the discussion.

  • No comments yet. Be the first.